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Today, catheter ablation has become a routine part of rhythm control in patients with atrial
fibrillation (AF). In the Czech Republic (C.R.), these procedures are recorded in a nationwide
registry, which is managed online and gives an overview on procedure rates and
development trends. Palliative procedures, i.e. AV node ablation, are infrequently used
nowadays and their rate did not change significantly within last 15 years. Contrary to that,
the rate of selective ablation procedures of AF is steeply rising. In the C.R., these
procedures are carried out in 10 centers, and 1590 ablation procedures of AF were carried
out in the year 2011. With its ablation rate per million inhabitants the C.R. ranks among the
highest in Europe. For ablation, radiofrequency energy is used most frequently (93%),
followed by cryoenergy (5% procedures), and laser energy (2% procedures). Of the
3-dimensional electroanatomic mapping methods the system Carto (66% ablations) and
NAV x-system (22% ablations) are used most frequently. Real-time imaging using intra-
cardiac echocardiography is widely used (73% ablation), which results in enhanced safety
of the procedures. Mortality associated with AF ablation is 0.04% (3 cases out of the total of
7300 ablation procedures in the registry).
& 2012 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o. All
rights reserved.
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Catheter ablation has become a routine part of the AF
management. The history of ablation started 30 years ago,
in 1982, when first patients with supraventricular arrhyth-
mias have been applied direct current (DC) into the His
bundle region. This resulted in complete AV block, that
prevented transmission of the electric impulse from the atria
to the ventricles. At the end of 80s the DC bursts were
replaced by a significantly friendlier application of the radio-
frequency (RF) energy. Some 10 years later, the first curative
interventions of AF were introduced. Then, the importance of
palliative ablation of the AV junction fell significantly. Today
this procedure is used for rate control in polymorbid patients
or in patients after resynchronization therapy of heart failure.
Cardiac surgeons were the first to carry out treatment
procedures to restore the heart rhythm. Until now, different
modifications of the original surgical procedure of the type
‘‘maze’’ are used. The principle is to create multiple incisions in
the atria, resembling a maze with just one correct way for
impulse transmission. This prevents the reentry mechanism.
At first, the cardiologists attempted to simulate these linear
lesions in the atria by the catheter, however, with available
methods and technologies the procedures were long and
complicated, with low success rate. A breakthrough in the
catheter treatment of AF was made by the finding, that
paroxysmal arrhythmia was frequently triggered by the ectopic
activity from the pulmonary veins. After a temporary period of
focal ablation, complete electrical pulmonary vein isolation has
been widely introduced. Later on, ablation for persistent and
even long-standing persistent forms of AF have been intro-
duced. In these patients reentry circuits or rotors in the atria
play a bigger role than foci. Although even in these patients
pulmonary veins isolation remains the base of catheter treat-
ment of AF, in order to achieve higher success rate, further
lesions in the left or in both atria have to be carried out.2. Indication for ablation
AF is associated with symptoms, lower quality of life, higher
morbidity and mortality. The hypothetic goals of ablation
include elimination of the arrhythmia with resulting allevia-
tion or diminishing of symptoms, better quality of life, low-
ering the risk of heart failure, stroke, peripheral embolism
and lower mortality. However, until now, objective data haveTable 1 – Indications for catheter ablation in patients with atr
Indications for catheter ablation of AF
Symptomatic AF refractory or intolerant to at least one Class 1 or 3 ant
Paroxysmal: Catheter ablation is recommended
Persistent: Catheter ablation is reasonable
Longstanding persistent: Catheter ablation may be considered
Symptomatic AF prior to initiation of antiarrhythmic drug therapy with
Paroxysmal: Catheter ablation is reasonable
Persistent: Catheter ablation may be considered
Longstanding persistent: Catheter ablation may be consideredproven reliably only the symptom alleviation and the quality
of life improvement. In the future, ablation may prove useful
to achieve other goals. To this time, however, ablation is
indicated mainly in symptomatic patients [1,2].
AF occurs frequently in patients with heart failure. The
responsible mechanism is scarring and myocardial fibrosis,
atrial dilatation and overload, and also the influence of
neurohumoral upregulation. The high atrial rate per se,
however, worsens atrial function and may lead to left ven-
tricular dysfunction (i.e. tachycardic cardiomyopathy). Higher
atrial rate, irregular ventricular rate, or even medication may
add to the development of heart failure. Studies have shown,
that after ablation of AV junction, as well as after elective
ablation for AF, improvement or even normalization of the
left ventricular function may occur. Thus, if AF is suspected
to be the main mechanism of left ventricular dysfunction,
selective catheter ablation should be considered.
Sinus rhythm restoration is usually associated with partial
or complete restoration of the above mentioned changes, i.e.,
with reverse remodeling. Some changes, e.g. fibrosis or
myocardial scarring, however, are irreversible. Generally, the
longer the AF duration, the more pronounced are the remo-
deling changes in the atria. Therefore the success rate of the
catheter ablation is primarily higher in the paroxysmal then
persistent forms. Also, more data are available in the litera-
ture on paroxysmal AF ablation.
Many randomized and observational studies compared
success rate of catheter ablation and pharmacological anti-
arrhythmic treatment of AF. In general, all of them proved
that catheter ablation was significantly better than pharma-
cological treatment in sinus rhythm preservation. These data
lead to the indications for catheter ablation (Table 1).
In the recently published Focused Update of the European
Society of Cardiology [3] there is focus on safety of the
catheter ablation for AF. These procedures are complex and
associated with some risk of complication. Data on complica-
tion rate are shown in the newly finished EURObservational
Research Programme, that involved 10 European countries
(including C.R.) and more than 1000 procedures, carried out
in specialized high-volume centers. Among severe complica-
tions, tamponade was in 1.3%, stroke in 0.6%, pericarditis in
2% and vascular complication in 1.3%. Some studies listed
not only clinically apparent but also silent embolizations,
diagnosed by MRI or ultrasound. The clinical impact of the
silent embolizations is not clear, however this risk needs to
be carefully considered, when selecting an ablation tool or
technology.ial fibrillation (AF).
iarrhythmic medication
I A
IIa B
IIb B
a Class 1 or 3 antiarrhythmic agent
IIa B
IIb C
IIb C
c o r e t v a s a 5 4 ( 2 0 1 2 ) e 3 5 2 – e 3 6 0e354Center selection also has to do with safety. As the risk of
complication is lower in high-volume centers, the guidelines
clearly state, they are valid only if procedures are carried out
by experienced operators.
Ablation is associated with increased risk of thromboem-
bolic complications. Therefore, there is consensus on antic-
oagulation in the peri-ablation period. Several studies have
shown, that ablation may be carried out with ongoing antic-
oagulation using vitamin K antagonists (VKA), with lower rate
of complication. This is valid especially for local vascular entry
complications. Therefore, in patient on VKA it is recom-
mended not to interrupt the treatment before the procedure.
The anticoagulation therapy should be kept in the therapeutic
range (optimally INR 2.0–2.5) throughout ablation. The experi-
ence with novel anticoagulants is limited in this respect. Some
data suggested higher complication rate of intervention on
continuing dabigatran treatment. However, it should be
stressed, that the net association of risk with continuing
anticoagulant treatment is not known. However, it is probably
sure to start these agents after the procedure. [3]2.1. What is the role of ablation in patients with AF?
The control of heart rhythm, heart rate, and prevention of
thromboembolic events are the three basic components of AF
treatment. The majority of studies, that compared rhythm vs.
rate control, did not find significant difference in morbidity or
mortality between these two methods. While the sinus
rhythm is more favorable, the advantage of maintaining sinus
rhythm is neutralized by the use of antiarrhythmics and their
adverse effects. Therefore, today, individual approach is pre-
ferred. In younger patients, first rhythm control should be1. IKEM Praha - Klinika kardiologie
2. FN Brno - Interní kardiologická klinika
3. Nemocnice Na Homolce - Kardiologické odd.
4. Nemocnice České Budějovice – kardiocentrum
5. VFN Praha - II. interní klinika kardiologie a angiologie 
6. Třinec - kardiocentrum
7. FNUSA Brno - II. interní klinika kardiologie a angiologie klinika
8. FNHK - I. interní kardioangiologická klinika
9. FN Olomouc - I. interní klinika
10. Artur Koblitz, s r.o. - kardiologie
11. Liberec – Kardiocentrum
12. Ústí nad Labem - Kardiologické odd.
13. FN Plzeň - Kardiologické odd., arytmologie
14. FN Motol - Dětské kardiocentrum
15. FN Královské Vinohrady Praha – III. interní - kardiologická klinika 
16. FN Brno - Pediatrická klinika
17. FN Ostrava - Kardiovaskulární odd.
18. FN Motol - Kardiologické oddělení
19. Karlovy Vary - Kardiocentrum
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Fig. 1 – Centers that carry out ablaattempted, while in the older, often polymorbid or less
symptomatic patients, rate control may be preferred.
In real life rhythm control seems to be a more favorable
approach. This is suggested by the registry RECORD AF [4]. In
the prospective study, rate vs. rhythm control was compared.
The study was fueled by data from physicians randomly
selected from the global list of office- or hospital-based
(university/nonuniversity, private/clinic) cardiologists. Finally,
data from 5 604 patients with AF from 532 centers from 21
countries in Europe, America and Asia were analyzed. The risk
of cardiovascular events, stroke and heart failure was lower
with rhythm control.
The prevalence of AF is estimated 1–2% in the population.
Based on the assumption, that half of the patients are
symptomatic, excluding polymorbid patients, ablation still
would be considered in a high percentage of patients. What is
the percentage of patients with AF that really undergo the
procedure?
According to the registry RECORD AF, 2% of treated patients
underwent the ablation, another 2% had pacemaker implanta-
tion and 0.3% patients undertook surgical treatment of AF.
The prospective study ATRIUM (registry of the morbidity of
outpatients with AF [5]) from a random sample of outpatient
clinics in Germany, brings another data on the current treat-
ment of patients with AF. The registry included data on 3 667
patients, mean age 72 years, 58% men. AF was paroxysmal in
27.1%, persistent or long-standing persistent in 25.7%, and
permanent in the full 41.6%. The mean time since diagnosis
was 61 months. The rate control was used in 75%, rhythm
control in 33% patients, often added to the rate control. In the
sample, 75% patients were treated with beta-blockers, 15%
calcium antagonists and 29% with digoxin. Full 46% patients
undertook cardioversion in the year pre-enrollment, of these6
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c o r e t v a s a 5 4 ( 2 0 1 2 ) e 3 5 2 – e 3 6 0 e355one half had electric cardioversion. Catheter ablation was
carried out in 5%, pacemaker or defibrillator implantation in
10%. It should be emphasized, that these data come from a
country that belongs to the most productive in Europe con-
cerning ablation rate per million inhabitants. In fact, catheter
ablation is carried out in 2–5% of patients, that are followed
and treated for AF in the developed countries of Europe.
2.2. Which technologies are used in catheter ablation?
Knowledge of pathophysiology and mechanism of AF onset
and preservation, and development of the catheter treatment
of this arrhythmia was associated with significant technolo-
gical development. The left atrium is approached transsep-
tally. The ablation is most commonly carried out by a
navigable catheter for mapping and application of radio-
frequency energy point-by-point. Apart from point-by-point
energy application, circular and semicircular catheters are
used, that enable at one time energy application around the
pulmonary vein orifice. Further, balloon catheters using
cryoenergy, laser or circular/network catheters are used in
practice, with radiofrequency energy aiming to achieve pul-
monary vein isolation by one or a few ablation energy
applications. Point-by-point ablation can also be used by all
sources of energy. The main advantage of balloon and75
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Fig. 3 – Trend in the AF ablationcircular catheters is the possibility of pulmonary vein isola-
tion by a low number of ablation energy applications.
The disadvantage is a certain limitation by the anatomy of
the left atrium. Further they may not be used for the AF
sources localized beyond pulmonary veins or for linear
ablation. The success rate of point-by-point and balloon
technology ablation is similar, however large comparative
studies are lacking.
AF ablation may be carried with simple fluoroscopic navi-
gation or using three-dimensional mapping systems.
The virtual maps obtained by these systems may be integrated
with 3-D images of the atria by CT, MRI or rotational angio-
graphy. The ablation may be easier using intracardiac echocar-
diography. The catheter may be navigated directly by the hand
of the operator or through distal navigation by the magnetic
field or by a robotic hand with navigable catheter sheath.
According to the EURObservational Research Programme [6],
which includes data from 1 391 ablations carried out between
2009 and 2010 in 10 European countries, ablation was carried
out for paroxysmal AF in 66.8% patients, for persistent AF in
27.6% and for long-standing persistent AF in 4.5%. Radio-
frequency energy was used for ablation in 88.4%, the catheter
with open cooling of the tip was used for application in 77.8%,
and circular catheter in 4.4%. Cryoenergy is reported in 13.4%
procedures and laser balloon in 0.8% procedures.66
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The ablation rate in the C.R. is recorded in the national
registry since 1996. The data collection is managed by the
Working Group on Arrhythmias and Cardiac Pacing of the
Czech Society of Cardiology. Since 2010, the registry has been
available in the on-line regime. In the registry, demographic
data (patient age and gender), indication for the procedure,
their order, and parameters (ablation duration and fluoro-
scopic time) are recorded, as well as data on the technology1295
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Catheter ablation for arrhythmia in the C.R. with popula-
tion of 10.2 million inhabitants is carried out in 19 centers
(Fig. 1). First ablation procedures in the C.R. were palliative,
i.e. AV transmission interruption using DC impulse. Later,
radiofrequency energy started to be used for this purpose.
The number of AV node ablation procedures did not change
during 15 years (Fig. 2), while the total number of ablation
procedures rose more than 4 times. Only in the last years the2769
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c o r e t v a s a 5 4 ( 2 0 1 2 ) e 3 5 2 – e 3 6 0 e357number of AV node ablation has been mildly rising, especially
in patients with AF and resynchronization therapy of heart
failure. In these cases the ablation allows full effect of
biventricular stimulation.
The rate of selective ablation for AF is further increasing.
Between 2000 and 2011 more then 7 300 AF ablation were carried
out in the C.R.. (Fig. 3). The spectrum of ablation is changing, so
the percentage of AF ablation out of the total number of ablation
procedures is rising (Fig. 4). In 2011, the ablation of AF constituted
36.5% of all ablation (Fig. 5). Full 66.3% were for paroxysmal AF,
22.8% for persistent AF, 5.8% for long-standing persistent AF a
5.1% for atrial tachycardias that arose after AF ablation.
The AF ablation is carried out in 10 centers with distinctly
different numbers of procedures. In 2011, 1590 AF ablation
were carried out in the C.R.. In one center the AF ablation rate
was over 400 per year, it was 200 in another 2 centers, andProcedur
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Fig. 7 – Ablation procedure time by type of atrial fibrilla100–200 in another 3 centers. The remaining centers made
below 100 procedures per year (Fig. 6). In 2012 AF ablation
started to be carried out in another 2 centers, thus newly, 12
centers will be involved in ablation.
Lack of data on follow-up and long-term success rate of the
procedures is the main limitation of the registry. The success
rate, however, can be estimated by the number of repeated
procedures for a given diagnosis. Last two years, repeated
procedures for AF have been carried out in 8% patients, with
median time until repeated procedure 9 months. The mean
duration of paroxysmal AF ablation (puncture - catheter
removal) is 210 min, of persistent AF 249 min, and of long-
standing persistent AF 287 min (Fig. 7). The fluoroscopic load
in the C.R. is generally low, with median fluoroscopic time
ranging from 15 min in paroxysmal AF ablation, to 20 min in
persistent AF ablation. (Fig. 8) This is probably due to frequente rate
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Long-term persistent ST post
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c o r e t v a s a 5 4 ( 2 0 1 2 ) e 3 5 2 – e 3 6 0e358use of pulse skiascopy, 3D-mapping methods and intracar-
diac echocardiography.
Radiofrequency energy is the most common energy for AF
ablation, i.e., in 93%. Cryoenergy was used in 5% and laser
energy in 2% of procedures. Among the 3D-mapping meth-
ods, the Carto system was used in 66% and NAV ix in 22%.
More than 60% of patients had cardiac CT before ablation.
In the C.R. 73% of procedures have been carried out under
intracardiac echocardiography control. It enables (1) real time
imaging of the heart anatomy, including pulmonary veins
morphology and the position of the esophagus to the left
atrium, (2) safe transseptal puncture, (3) navigation of the
ablation and mapping catheter in the atrium, (4) energytitration, tracking of changes of the left atrial wall morphol-
ogy during ablation (5) early monitoring of the thrombus
formation on the catheter, sheath or in the atrium. and
(6) early diagnosis of complications, e.g. pericardial effusion
or tamponade.
However, intracardiac echocardiography does not fully
replace transesophageal echocardiography in excluding left
atrial thrombosis. At the time of joined European and American
guidelines for ablation (EHRA/HRS/ECAS, 3) 50% of the panel
reported routine use of this method. Thus, the use of intracar-
diac echocardiography in the C.R. is high above average.
The complication rate is also followed in the national
registry, however it is probably significantly underreported.
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Even though ablation procedure is generally considered safe,
it can be associated with mortality. In the C.R. there have
been 3 reported deaths out of the total of more than 7 300 AF
ablation procedures. (0.04%). This is less, than reported in the
recent whole world overview, where death is reported in 32
out of 32,569 (0.1%) patients, who underwent 45,115 proce-
dures for AF [7]. It is encouraging, that esophageal fistula, a
severe complication with high mortality has not yet been
reported. This is probably due to lower energy used for
ablation in the C.R., i.e. maximum 25–30 W with radiofre-
quency ablation at the posterior wall.
2.4. Comparison of the AF ablation rate between C.R. and
Europe
In Europe, the rate of invasive procedures for arrhythmias,
including catheter ablation is listed in a yearly published
overview called White book of the European Heart Rhythm
Association (EHRA). In 2012 EHRA published the 5th edition,
that included data from national organizations from 46
countries (out of total 54 member countries) of the European
Society of Cardiology [8].
AF catheter ablation has been only recently followed
separately. Some national organizations, however, have no
data available or with delay. Other countries only estimate
their numbers. In many countries, that provide data for the
White book, AF ablation is carried out rarely or not at all. The
total rate of ablation for arrhythmias in selected European
countries are shown in the Fig. 9. With the ablation rate of
440 per million inhabitants C.R. belongs to the countries with
the highest number of procedures. The situation is similar for
AF ablation (Fig. 10). The calculation of procedure rate per
health care expenditure in a given country is also interesting.
With the expenditure equivalent 1590 USD per person and
year the C.R. is deep below the European average which was2 786 USD. On the contrary, with the rate of arrhythmia
procedures (implantation of pacemakers, defibrillators, abla-
tion for arrhythmia including AF) per health care expendi-
ture, the C.R. ranks among the best in Europe, that suggests
very effective use of resources.3. Conclusions
Catheter ablation has become a routine part of heart rhythm
control in patients with AF. Currently 2–5% treated patients
undergo these procedures, however this depends on the
number of interventions in each country. Approximately 2/3
of ablation are for paroxysmal AF and 1/3 for persistent and
long-standing persistent AF. Comparison of the Czech regis-
try data with other countries is difficult, as detailed data are
lacking. Relevant summary data are brought together only by
the White book EHRA. With the AF ablation rate 156 per
million inhabitants, C.R. belongs to the highest ranking
countries in Europe. The technologies used and parameters
of the procedures correspond with findings from large cen-
ters that carry out ablation.
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